ANI Pharmaceuticals Earnings
NASDAQ: ANIPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Fri, Nov 6, 2026
Fiscal period
Sep/2026
EPS estimate
$1.80
ANI Pharmaceuticals earnings summary
ANI Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 6, 2026, with analysts expecting EPS of $1.80. In its most recent report on Aug 7, 2026 (Q2 2026), ANIP posted EPS of $1.05. Revenue for the quarter was $266.0 million.
Quarterly EPS is up 191.7% from the same quarter a year earlier. Across the last 16 reports, ANIP shares moved an average of 4.9% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
ANIP earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 7, 2026 | — | $1.05 | — | -2.2% |
| May 8, 2026 | — | $1.28 | — | -4.7% |
| Jan 12, 2026 | — | $1.14 | — | -2.2% |
| Nov 7, 2025 | — | $1.13 | — | -7.1% |
| Jul 23, 2025 | — | $0.36 | — | -5.3% |
| May 9, 2025 | — | $0.69 | — | -9.5% |
| Jan 13, 2025 | — | $-0.45 | — | +0.3% |
| Nov 8, 2024 | — | $-1.27 | — | -7.9% |
| Aug 6, 2024 | — | $-0.14 | — | +3.7% |
| May 10, 2024 | — | $0.82 | — | -9.7% |
| Feb 29, 2024 | — | $0.05 | — | +0.4% |
| Nov 8, 2023 | — | $0.45 | — | -1.5% |
| Aug 9, 2023 | — | $0.29 | — | -4.7% |
| May 8, 2023 | — | $0.06 | — | +10.3% |
| Mar 9, 2023 | — | $-0.29 | — | -3.7% |
| Nov 9, 2022 | — | $-0.55 | — | +5.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.